Electrical Storm in Patients With Hypertrophic Cardiomyopathy
Authors, Journal, Affiliations, Type, DOI
- Authors: Pierre Groussin, Melvyn Dezecot, Donovan Decaudin, Dominique Pavin, Sandro Ninni, Cédric Klein, Pierre Ollitrault, Laure Champ Rigot, Jonaz Font, Antoine Da Costa, Jean-Marc Sellal, Néfissa Hammache, Alexandre Salaun, Charles Guenancia, Philippe Mabo, Karim Benali, Raphaël Martins
- Journal: JACC: Clinical Electrophysiology 2025;11(11):2323–2334
- Affiliations: University of Rennes, CHU Rennes, INSERM LTSI–UMR 1099 (Rennes); Lille University Hospital; Caen University Hospital; University Hospital of Saint-Etienne; Nancy University Hospital; Dijon University Hospital (France)
- Type: Retrospective, multicentre cohort study (6 French tertiary centres, January 2017 to March 2023)
- DOI: 10.1016/j.jacep.2025.06.035
Overview
This is the first multicentre cohort dedicated to electrical storm in hypertrophic cardiomyopathy. Among 23 patients, monomorphic ventricular tachycardia was the dominant rhythm (78%), amiodarone and beta-blockers were the mainstays of management, and radiofrequency ablation was performed in 43.5% without a demonstrable association with arrhythmia recurrence or survival. In-hospital mortality was 9%, and 26% of patients died over a median follow-up of 18 months. Five patients (21.7%) had an apical aneurysm, reinforcing the high-risk phenotype. The study is small, retrospective and unadjusted, so its ablation findings are hypothesis-generating rather than definitive.
Keywords
Hypertrophic cardiomyopathy; Electrical storm; Ventricular tachycardia; Catheter ablation; Implantable cardioverter-defibrillator
Key Takeaways
Study design and population
- Six French tertiary centres, January 2017 to March 2023; 23 consecutive patients admitted to intensive care with electrical storm complicating hypertrophic cardiomyopathy.
- Electrical storm was defined as at least three distinct episodes of sustained ventricular tachycardia or ventricular fibrillation within 24 hours, separated by at least 5 minutes, each requiring termination by an intervention.
- Mean age 61.5 ± 15.2 years; 17 men (73.9%); mean left ventricular ejection fraction 50% ± 14%; 10 patients (43%) had an ejection fraction ≤50%.
- Five patients (21.7%) had a left ventricular apical aneurysm; 10 (43.4%) had a history of ventricular arrhythmia, including 3 with previous electrical storm; 6 (26.1%) had prior ventricular arrhythmia ablation; 17 (73.9%) had an implantable cardioverter-defibrillator.
- A genetic mutation was identified in 10 patients (43.5%): MYBPC3 (4), TNNT2 (2), LMNA (1), FLNC (1); one patient had Fabry disease and one had MELAS.
Electrical storm characteristics and management
- The arrhythmia was monomorphic ventricular tachycardia in 18 patients (78.3%) and ventricular fibrillation in 7 (30.4%); two patients had both.
- A trigger was documented in only 5 patients (21.7%); the majority had no identified trigger.
- Therapies before admission: antitachycardia pacing only in 4 (17.4%), shocks only in 5 (21.7%), both in 9 (39.1%), and pharmacological termination only in 5 (21.7%).
- Antiarrhythmic drugs: amiodarone 20 (87.0%), beta-blockers 16 (70.0%), lidocaine 9 (39.1%), magnesium sulfate 8 (34.8%).
- Device reprogramming in 7 (30.4%); deep sedation and intubation in 3 (13.0%); extracorporeal membrane oxygenation in 2 (8.6%); vasoactive drugs in 5 (21.7%); stellate ganglion block in 1 (4.3%).
- Five patients (21.7%) had cardiogenic shock; no intra-aortic balloon pump or Impella was used; two patients required haemodialysis.
Catheter ablation
- Ten patients (43.5%) underwent radiofrequency ablation for persistent ventricular arrhythmia despite antiarrhythmic drugs; all had monomorphic ventricular tachycardia, including three with an apical aneurysm.
- Ablation was performed 9 ± 6 days after electrical storm onset. Eight procedures were endocardial and two epicardial; one patient underwent ablation under extracorporeal membrane oxygenation.
- Procedural outcome: complete acute success in 3 (30%), partial success in 1 (10%), failure in 3 (20%), and undetermined in 3 (30%).
- One patient developed cardiac tamponade requiring percutaneous drainage.
- In-hospital ventricular arrhythmia recurrence occurred in 8 patients (34.8%): 2 of the ablated group (25%) and 6 of the non-ablated group (75%); risk ratio 0.67 (95% CI 0.37–1.22; P = 0.380).
- In-hospital death occurred in 2 patients (8.6%), from multiorgan failure and cardiogenic shock. Radiofrequency ablation was not significantly associated with in-hospital mortality (OR 1.33; 95% CI 0.05–36.9; P = 0.846).
Long-term outcomes
- Median follow-up was 18 months (IQR 6–35 months). Seven patients (30%) had recurrent sustained ventricular tachycardia, including 4 who had undergone ablation.
- Radiofrequency ablation was not associated with ventricular arrhythmia recurrence (HR 2.52; 95% CI 0.56–11.4; P = 0.231) or survival (P = 0.125).
- One patient underwent heart transplantation one month after electrical storm for persistent ventricular arrhythmia.
- Among the 21 patients discharged, 4 (19%) died: three from end-stage heart failure and one from septic shock. One-year survival was 82.7%, and 26% of the cohort died over 18 months.
Interpretation
- Electrical storm in hypertrophic cardiomyopathy is predominantly monomorphic ventricular tachycardia and often responds to amiodarone and beta-blockers; deep sedation, mechanical support and neuromodulation are needed in a minority.
- In this cohort, ablation did not improve recurrence or survival. The authors attribute this in part to the limited use of epicardial ablation (2 patients), a single procedure per patient, and the intramural/epicardial nature of the substrate.
- The high mortality (9% in hospital, 26% at 18 months) reflects the severity of electrical storm in this population.
- The five patients with apical aneurysm (21.7%) represent a high-risk phenotype; the paper cites a five-fold increase in arrhythmic events with apical aneurysm.
Limitations of the document
- Small, retrospective, single-arm comparison — 23 patients, no concurrent control, unmeasured confounding; the ablation and non-ablation groups differed at baseline (the ablation group tended to have lower ejection fraction and more prior ventricular arrhythmia).
- No adjusted multivariable analysis — the number of events was too small; the ablation associations are exploratory.
- Incomplete imaging and phenotype data — cardiac magnetic resonance and detailed echocardiography were not available for all patients.
- Limited ablation strategy — mostly endocardial, only two epicardial procedures, one procedure per patient; the results may understate the effect of a combined endo-epicardial, repeat-procedure strategy.
- No quantification of arrhythmia burden over time and no central adjudication of recurrence.
- Referral bias — tertiary-centre intensive-care cohort; the findings may not apply to less severe electrical storm.
Key Concepts Mentioned
- concepts/Electrical-Storm — the clinical syndrome and definition
- concepts/VT-in-HCM — the HCM-specific VT substrate and ablation outcomes
- concepts/VT-Ablation — the procedural context
- entities/HCM — the underlying cardiomyopathy
- entities/ICD — device therapy and reprogramming
Key Entities Mentioned
- Hypertrophic cardiomyopathy
- Implantable cardioverter-defibrillator
- Apical aneurysm
Wiki Pages Updated
- Created:
wiki/sources/hcm-electrical-storm-jacep-2025.md - Updated:
wiki/concepts/VT-in-HCM.md - Updated:
wiki/concepts/Electrical-Storm.md - Updated:
wiki/entities/HCM.md - Updated:
wiki/concepts/HCM-Management.md - Updated:
wiki/sourceindex.md - Updated:
wiki/wikiindex.md - Updated:
log.md